A new study conducted by the University of Washington in St. Louis found the rate of xylazine-positive tests in opioid-addicted patients cared for in one of the city’s maternity wards surged from zero percent in December 2022 to 100% by July 2023.
“These results underscore the critical need to further study the impact of xylazine on obstetric outcomes,” concluded lead author Dr. Cassandra Trammel.